Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/FLEXION-THERAPEUTICS-INC-15749853/news/Flexion-Therapeutics-Enrolls-First-Patient-in-Phase-2-Pharmacokinetics-and-Safety-Study-of-ZILRETT-25634898/?utm_source=whatsapp&utm_medium=social&utm_campaign=share